XML 24 R4.htm IDEA: XBRL DOCUMENT v3.24.4
STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:    
Research and development $ 18,161,451 $ 22,471,496
General & administrative 8,191,023 9,004,578
Total operating expenses 26,352,474 31,476,074
Operating loss (26,352,474) (31,476,074)
Interest expense, net (745,673) (675,416)
Other income (expense) 177,682 (42,813)
Net loss (26,920,465) (32,194,303)
Modification of warrants (659,456) (171,552)
Net loss available to common shareholders $ (27,579,921) $ (32,365,855)
Net loss per common share - basic and diluted $ (0.51) $ (0.73)
Weighted average common shares outstanding - basic and diluted 54,044,989 44,479,865